None
Conditions
Interventions
Remimazolam group:Anesthesia Induction: Alfentanil 6 µg/kg + Remimazolam 0.2 mg/kg
Anesthesia Maintenance: Remimazolam 1 mg/kg.h
Ciprofol group:Anesthesia Induction: Alfentanil 6 µg/kg + Ciprofol 0.4 mg/kg
Anesthesia Maintenance: Ciprofol 1 mg/kg.h
Sponsors
Xiangya Hospital, Central South University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients scheduled for painless fiberoptic bronchoscopy in our hospital; 2.No history of anaesthetic allergy; 3.No recent use of sedatives and analgesics; 4.Patients and family members were informed and consented to the study.
Exclusion criteria
Exclusion criteria: 1.Respiratory failure(PaO250mmHg); 2.NYHA Class IV, severe arrhythmias, and structural heart disease; 3.acute cerebral infarction or cognitive/mental disorders; 4.Liver function: Child-C or chronic kidney disease:CKD stage 4-5; 5.communication difficulties; 6.abnormal coagulation function; 7.difficult airway; 8.Pregnant women and nursing patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anesthesia Induction Success Rate;Incidence of Intraoperative Hypotention;Incidence of Intraoperative Hypoxemia; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction score;Pain Numeric Rating Scale (NRS);Operator satisfaction score;Adverse Reaction Incidence Rate; | — |
Countries
China
Contacts
Public ContactYang Yong
Xiangya Hospital, Central South University
Outcome results
None listed